GSA Capital Partners’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-72,976
Closed -$1.59M 1696
2025
Q4
$1.59M Buy
72,976
+13,324
+22% +$277K 0.14% 157
2025
Q3
$1.28M Buy
59,652
+45,200
+313% +$1.01M 0.11% 261
2025
Q2
$371K Buy
+14,452
New +$423K 0.03% 1126
2023
Q4
Sell
-21,884
Closed -$687K 1491
2023
Q3
$687K Buy
+21,884
New +$688K 0.06% 601
2022
Q1
Sell
-4,407
Closed -$259K 1394
2021
Q4
$259K Sell
4,407
-874
-17% -$53.1K 0.03% 1040
2021
Q3
$321K Sell
5,281
-33,336
-86% -$1.95M 0.03% 973
2021
Q2
$2.32M Buy
+38,617
New +$1.93M 0.26% 43
2017
Q2
Sell
-25,084
Closed -$548K 1663
2017
Q1
$548K Sell
25,084
-2,810
-10% -$63.5K 0.03% 1045
2016
Q4
$629K Buy
+27,894
New +$673K 0.04% 845

Other funds holding ATEX

GSA Capital Partners's ATEX Position: Q1 2026 in Review

GSA Capital Partners sold out of Anterix (ATEX) in Q1 2026, closing a stake of 72,976 shares — an estimated $1.59M sold.

GSA Capital Partners first reported a position in ATEX in Q4 2016 and held it in 9 quarters. The position peaked at $2.32M in Q2 2021. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • GSA Capital Partners reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 72,976 Anterix shares in Q1 2026, an estimated $1.59M.
  • GSA Capital Partners first reported a position in Anterix in Q4 2016 and held it in 9 quarters.
  • GSA Capital Partners's Anterix position peaked at $2.32M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.